IAM
LIAN

Innovis Asset Management’s LianBio American Depositary Shares LIAN Stock Holding History

Innovis Asset Management’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-176,192
Closed -$289K – 175
2022
Q4 		$289K Buy
+176,192
New +$275K 0.13% 106

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Innovis Asset Management's LIAN Position: Q1 2023 in Review

Innovis Asset Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2023, closing a stake of 176,192 shares — an estimated $289K sold.

Innovis Asset Management first reported a position in LIAN in Q4 2022 and held it in 1 quarter. The position peaked at $289K in Q4 2022. 36 funds tracked by Wall St. Rank hold LIAN as of Q1 2023.

  • Innovis Asset Management reported no remaining LianBio American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Innovis Asset Management sold 176,192 LianBio American Depositary Shares shares in Q1 2023, an estimated $289K.
  • Innovis Asset Management first reported a position in LianBio American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Innovis Asset Management's LianBio American Depositary Shares position peaked at $289K in Q4 2022.
  • 36 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2023.

Based on Innovis Asset Management's 13F filing for Q1 2023, filed 10 May 2023.